−0GBP
−26.83 MGBP
50.02 M
About FARON PHARMACEUTICALS OY ORD NPV (DI)
Sector
CEO
Markku Tapani Jalkanen
Headquarters
Turku
Website
Employees (FY)
34
Founded
2003
ISIN
FI4000153309
FIGI
BBG009YWHTF4
Faron Pharmaceuticals Oy is a clinical stage biopharmaceutical company, which engages in the development of drugs to treat acute respiratory distress syndrome. Its main drug candidates include Traumakine and Bex. The company was founded by Juho Markku Jalkanen, Sirpa Tuulikki Jalkanen, Matti Esa Manner, Juha Veikko Peltola, Marko Salmi, Katriina Peltola and Maija-Leena Hollmen, and Markku Tapani Jalkanen in 2003 and is headquartered in Turku, Finland.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of FARN is 118 GBX — it has decreased by 1.67% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange FARON PHARMACEUTICALS OY ORD NPV (DI) stocks are traded under the ticker FARN.
FARON PHARMACEUTICALS OY ORD NPV (DI) is going to release the next earnings report on Aug 27, 2024. Keep track of upcoming events with our Earnings Calendar.
FARN stock is 8.70% volatile and has beta coefficient of 0.37. Check out the list of the most volatile stocks — is FARON PHARMACEUTICALS OY ORD NPV (DI) there?
One year price forecast for FARON PHARMACEUTICALS OY ORD NPV (DI) has a max estimate of 4 GBX and a min estimate of 2 GBX.
FARN earnings for the last quarter are −0.19 GBX whereas the estimation was −0.26 GBX which accounts for 26.67% surprise. Estimated earnings for the next quarter are −0.17 GBX. See more details about FARON PHARMACEUTICALS OY ORD NPV (DI) earnings.
FARON PHARMACEUTICALS OY ORD NPV (DI) revenue for the last quarter amounts to 0 GBX despite the estimated figure of 0 GBX. In the next quarter revenue is expected to reach 4.34 K GBX.
Yes, you can track FARON PHARMACEUTICALS OY ORD NPV (DI) financials in yearly and quarterly reports right on TradingView.
FARN stock has fallen by 12.59% compared to the previous week, the month change is a 34.08% fall, over the last year FARON PHARMACEUTICALS OY ORD NPV (DI) has showed a 62.18% decrease.
FARN net income for the last quarter is −14.93 M GBP, while the quarter before that showed −11.80 M GBP of net income which accounts for −26.50% change. Track more FARON PHARMACEUTICALS OY ORD NPV (DI) financial stats to get the full picture.
Today FARON PHARMACEUTICALS OY ORD NPV (DI) has the market capitalization of 86.51 M, it has decreased by 10.41% over the last week.
No, FARN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, FARN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FARON PHARMACEUTICALS OY ORD NPV (DI) stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 34.00 employees. See our rating of the largest employees — is FARON PHARMACEUTICALS OY ORD NPV (DI) on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So FARON PHARMACEUTICALS OY ORD NPV (DI) technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating FARON PHARMACEUTICALS OY ORD NPV (DI) stock shows the strong sell signal. See more of FARON PHARMACEUTICALS OY ORD NPV (DI) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on FARON PHARMACEUTICALS OY ORD NPV (DI) future price: according to them, FARN price has a max estimate of 428.45 GBX and a min estimate of 171.38 GBX. Read a more detailed FARON PHARMACEUTICALS OY ORD NPV (DI) forecast: see what analysts think of FARON PHARMACEUTICALS OY ORD NPV (DI) and suggest that you do with its stocks.